# HMPL004-6599 Phase I Dose-escalating Study

> **NCT03597971** · PHASE1 · TERMINATED · sponsor: **Nutrition Science Partners Limited** · enrollment: 32 (actual)

## Conditions studied

- Ulcerative Colitis
- Crohn Disease

## Interventions

- **DRUG:** HMPL004-6599
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03597971
- **Lead sponsor:** Nutrition Science Partners Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-03-20
- **Primary completion:** 2018-11-19
- **Final completion:** 2018-11-19
- **Target enrollment:** 32 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2019-12-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03597971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03597971, "HMPL004-6599 Phase I Dose-escalating Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03597971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*